Bharat Book Bureau Announces Upcoming Conference “14th Biosimilars Congregation 2019” to be held on 12th December 2019 in Mumbai, India.
“Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars”
According to a recent report by Morgan Stanley, as many as nine drugs in the biologics category have either gone off patent or will do so by 2025. Their total revenue was $62 billion (around INR 4.3 lakh crore) in 2018. This creates a major opportunity for their respective biosimilars. The research firm estimates that revenue of these biosimilars will grow by 24 per cent annually for seven years to $13.3 billion in 2025 (around INR 93,000 crore) in the US and Europe. That offers a big opportunity. the global market for biosimilars will be $240 billion and the Indian market will be over $35 billion by 2030
The 14th Biosimilars Congregation 2019 will be your opportunity with leading industry experts to discuss from development, manufacturing to commercialization – The current landscape, legal, regulatory, funding, challenges, market access strategy, business models and how to get to market
14th Biosimilars Congregation 2019 conference, to be held on 12th December 2019 in Mumbai, India. 14th Biosimilars Congregation 2019 brings together scientists, researchers and CROs from around the world.
At 14th Biosimilars Congregation 2019 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community
Follow the link for Registration: https://www.bharatbook.com/events/14th-biosimilars-congregation-2019/11
Why to attend?
Join your peers around the world focused on learning about Biologics and Biosimilars related advances, which is your single best opportunity to reach the largest assemblage of participants from the Biosimilars community, conduct demonstrations, distribute information, meet with current and potential professionals, make a splash with new research works, and receive name recognition at this 1-day event. Well-renowned speakers, the most recent research, advances, and the newest updates in Biologics and Biosimilars are hallmarks of this conference.
We look forward to see you personally at our esteemed event.
KEY THEMES DISCUSSED:-
– Biosimilar companies ‘ market assessment – Where are we to ahead?
– Present state and future scenario of the biosimilar market.
– Why does India need biotechnology to guarantee the safety of food, feed and nutrition?
– What are Indian institutes and scientists ‘ innovative biotechnological methods?
– Current landscape and policy updates for global biosimilars
– Discussing pricing approach and value management as a growing need
– Current challenges in developing biosimilars
– Scientific and strategic approaches taken for successfully developing of follow-on-biologics
WHO SHOULD ATTEND AND WHO YOU’LL MEET:-
CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:
– Biopharmaceuticals/ Biotherapeutics
– Follow on Biologics/Follow on Proteins
– Biologics/Biotechnology/ Bio generics
– Legal Affairs
– Intellectual Property
– Health Economics
For Upcoming Conferences: https://www.bharatbook.com/events
About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 4,80,000 reports and insights that includes latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters, Conferences and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.